Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections

Frontline Gastroenterol. 2021 Mar 11;13(1):86-88. doi: 10.1136/flgastro-2021-101818. eCollection 2022.

Rooshi Nathwani^{1

2}, David Kockerling^{1

2}, Benjamin H Mullish^{1

2}, Alexander Cole^{1

2}, Maud Lemoine^{1

2}, Charalambos Gustav Antoniades^{1

2}, Mark R Thursz^{1

2}, Ameet Dhar^{1

2}

¹ Division of Digestive Diseases, Imperial College London, London, UK.
² Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK.

No abstract available

Keywords: bacterial infection; cirrhosis; portal hypertension.